| CSB00024 | 注射用重组人干扰素α－2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2000-10-18 | 安徽安科生物高技术有限责任公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2005-08-19 | view |
| CYSB0700002 | 注射用重组人干扰素α2b（酵母） | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2008-04-29 | 上海万兴生物制药有限公司 | Shanghai Wanxing Biological Pharmaceutical Co Ltd | Certificate Issued | 2009-07-13 | view |
| CYSB0700001 | 注射用重组人干扰素α2b（酵母） | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2007-05-18 | 上海万兴生物制药有限公司 | Shanghai Wanxing Biological Pharmaceutical Co Ltd | Certificate Issued | 2008-02-18 | view |
| CSL20020008 | 注射用重组人干扰素α2b脂质体 | Recombinant Human Interferon α2b | Lyophilized | Biological Products(4) | New Drug Application | 2002-05-31 | 安徽安科生物工程股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | Certificate Issued | 2004-10-15 | view |
| CYSB0500159 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2005-10-13 | 浙江北生药业汉生制药有限公司 | Zhejiang Hansheng Pharmaceutical Co Ltd of Beisheng Pharma | Certificate Issued | 2006-04-04 | view |
| CYSB1600190 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2017-05-11 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2018-06-28 | view |
| CYSB2000401 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-12-29 | 北京远策药业有限责任公司 | Beijing Yuance Pharmaceutical Co Ltd | In Review | 2022-01-27 | view |
| CYSB1100254 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2011-11-01 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2013-01-10 | view |
| X0300235 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2003-01-21 | 哈药集团生物工程有限公司 | Harbin Pharmaceutical Group Bioengineering Co Ltd | Certificate Issued | 2003-06-06 | view |
| CYSB2000400 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-12-29 | 北京远策药业有限责任公司 | Beijing Yuance Pharmaceutical Co Ltd | In Review | 2022-01-27 | view |
| CYSB1100255 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2011-11-01 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2013-01-10 | view |
| CYSB2000125 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-06-04 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-06-03 | view |
| CXSS0500100 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products(3) | New Drug Application | 2005-09-13 | 北京凯因生物技术有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2009-12-21 | view |
| CYSB2000124 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-06-04 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-06-03 | view |
| X0401583 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2005-01-20 | 哈高科白天鹅药业集团有限公司 | Harbin High-Tech Group Baitian'er Pharmaceutical Co Ltd | Certificate Issued | 2005-07-15 | view |
| X0300236 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2003-01-21 | 哈药集团生物工程有限公司 | Harbin Pharmaceutical Group Bioengineering Co Ltd | Certificate Issued | 2003-06-06 | view |
| CYSB2000126 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-06-04 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-06-03 | view |
| CSL01001 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products(3) | New Drug Application | 2001-01-12 | 北京远策药业有限责任公司 | Beijing Yuance Pharmaceutical Co Ltd | Certificate Issued | 2002-05-27 | view |
| CYSB2000402 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-12-29 | 北京远策药业有限责任公司 | Beijing Yuance Pharmaceutical Co Ltd | In Review | 2022-01-27 | view |
| X0401584 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2005-01-20 | 哈高科白天鹅药业集团有限公司 | Harbin High-Tech Group Baitian'er Pharmaceutical Co Ltd | Certificate Issued | 2005-07-15 | view |
